- Patient/Guest
- Phlebotomist
- Updates
| Lipid LDL Test | - |
|---|
|
Measure lipid parameters with LDL |
||
| Synonym | See updates | |
| Test Code | CDBIOPR0019 | |
| Test Type | Biochemistry | |
| Pre-Test Condition | See updates | |
| Report Availability | 1 D(s) | |
| # Test(s) | Multiple | |
| Test details | Sample Report |
|---|---|
| Lipid LDL Test |
|
| Synonym | See updates | ||
| Test Code | CDBIOPR0019 | ||
| Test Category | Cardiovascular disorders | ||
| Pre-Test Condition | See updates | ||
| |
Medical History | See updates | |
| Report Availability | 1 D(s) | ||
| Specimen/Sample | Serum; 2 mL; SST | ||
| Stability @21-26 deg. C | 6 Hr(s) | ||
| Stability @ 2-8 deg. C | 7 D(s) | ||
| Stability @ Frozen | 1 M(s) | ||
| # Test(s) | Multiple | ||
| Processing Method | Spectrophotometry | ||
| **Lipid Profile with LDL Direct****FDA Status**: Standard laboratory procedure under CLIA; no specific FDA approval required.**Other Names**: Extended Lipid Panel, Direct LDL Test.**Historical Breakthrough**: Developed in the 1990s to improve lipid assessment, advancing cardiology.**Key Purpose and Impact**: Measures total cholesterol, HDL, direct LDL, and triglycerides for precise cardiovascular risk assessment.**Preparation and Patient History**: Fasting blood; report heart disease history or lipid therapy.**Consent Requirement**: Standard consent for diagnostic testing.**Clinical Value**: Sensitivity ~95%; specificity ~95%; detects dyslipidemia in ~85% of cases; guides therapy.**References Cited**: Testing.com Lipid Tests 2023; Labcorp Direct LDL Test 2025; UpToDate Dyslipidemia 2025 |
